In significant leadership news, Karen S. Lynch has stepped down from her role as President and CEO of CVS Health, with David Joyner taking her place. This shift marks a notable transition in the company’s leadership, as CVS navigates its future direction under new guidance.
Medicaid Timing Mismatch Cited as a Headwind by UnitedHealth Group and Elevance Health
Both UnitedHealth and Elevance Health have pointed to the Centers for Medicare & Medicaid Services timing mismatch as a key challenge impacting their earnings. Elevance, in particular, reported a third-quarter net income of $1 billion, a 22.5% decrease compared to the $1.3 billion in the same period of 2023. Despite this decline, the company’s net income for the nine months ending September 30 reached $5.5 billion, a slight increase from last year’s $5.1 billion.
Shares of Elevance Health fell 12% on Thursday after the health insurer adjusted its full-year earnings forecast, according to Seeking Alpha. CEO Gail Boudreaux echoed concerns voiced by UnitedHealth earlier in the week, stating that the mismatch between Medicaid rates and patient acuity has been a significant earnings drag.
Medicaid Redeterminations and Rate Mismatches Create Challenges
The core of the issue lies in state customer rate actions that have not yet accounted for the higher acuity of Medicaid members who remain enrolled after the redetermination process. According to UnitedHealth, this mismatch has created an earnings headwind as Medicaid members require higher levels of care than current rates reflect.
Boudreaux expressed confidence in the long-term potential of Elevance’s diverse business segments despite these challenges, saying, “We expect Medicaid rates will align with the needs of our members in time, and are taking proactive actions to enhance operational efficiencies that will ensure we emerge from this period even stronger.”
Its Importance
Elevance’s third-quarter performance was significantly affected by higher-than-expected medical expenses, according to Seeking Alpha. However, the company did see revenue growth, thanks to higher premium yields in its Health Benefits segment and increased product revenue from CarelonRx. These gains were partially offset by attrition in the Medicaid business.
The Broader Trend
Shares of other peer insurers also took a hit in premarket trading, including Molina Healthcare (-11.18%), Centene Corporation (-8%), CVS Health (-1.68%), and Humana (-2.18%), Seeking Alpha reported.
Earlier this week, during UnitedHealth’s earnings call, CFO John Rex highlighted another issue plaguing insurers: a “pronounced upshift in coding intensity by hospitals.” Some hospitals have increased their coding intensity by over 20%, contributing to rising costs in the healthcare system. Rex also pointed out a rapid rise in the prescribing of high-cost specialty medications for cardiovascular diseases, autoimmune disorders, and cancer. The Inflation Reduction Act, which eliminated the individual coinsurance requirement during the catastrophic coverage phase, may have accelerated this trend, Rex suggested.
